The distressed biotech firm, NovaGen Therapeutics, faced critical monetary difficulties stemming from unsuccessful clinical trials and mounting debt. Their internal leadership lacked the skill to address the https://deweydvcw832019.blogdigy.com/biotech-cfo-services-a-case-study-in-financial-recovery-66033952